Alx oncology holdings inc says entered into a clinical trial collaboration with merck

Alx oncology holdings inc - entered into a clinical trial collaboration with merck.alx oncology - collaboration with merck to evaluate combination of alx148 & keytruda for treatment of patients with head & neck squamous cell carcinoma.alx oncology holdings - under terms of agreement, co will conduct a phase 2 program comprising two separate phase 2 studies.
ALXO Ratings Summary
ALXO Quant Ranking